These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6104413

  • 1. Drug treatment of the overactive detrusor.
    Andersson KE, Ulmsten U.
    Acta Pharmacol Toxicol (Copenh); 1980; 46 Suppl 1():7-11. PubMed ID: 6104413
    [No Abstract] [Full Text] [Related]

  • 2. [The effects of drugs on vesico-urethral function].
    Gerstenberg TC, Andersen JT, Walter S.
    Nord Med; 1981 Dec; 96(12):310-2. PubMed ID: 6118853
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological management of common urodynamic problems.
    Milroy E.
    Urol Clin North Am; 1979 Feb; 6(1):265-72. PubMed ID: 34915
    [No Abstract] [Full Text] [Related]

  • 4. [Pharmacological treatment of urinary incontinence and difficulty in emptying the bladder in women].
    Thind P, Lose G.
    Ugeskr Laeger; 1985 Dec 02; 147(49):3989-92. PubMed ID: 2868553
    [No Abstract] [Full Text] [Related]

  • 5. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM.
    Clin Ther; 1999 Apr 02; 21(4):634-42. PubMed ID: 10363730
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial.
    Petersen T, Jakobsen J.
    J Neurol Neurosurg Psychiatry; 1987 Oct 02; 50(10):1331-6. PubMed ID: 3681312
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Neurogenic disturbances of the bladder treated with flavoxate (Urispadol)].
    Pedersen E, Bjarnason EV, Hansen PH.
    Ugeskr Laeger; 1973 Oct 22; 135(43):2313-7. PubMed ID: 4590632
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pharmacological evaluation of efficacy and safety of propiverine hydrochloride in patients of overactive bladder--relationship between urodynamic observation and propiverine pharmacokinetics--].
    Sugiyama T, Shimizu N, Hashimoto K, Yoshioka N, Hanai T, Matsumoto S, Uemura H.
    Nihon Hinyokika Gakkai Zasshi; 2005 Nov 22; 96(7):670-7. PubMed ID: 16363652
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Electromyography of the detrusor muscle.
    Stanton SL, Hill DW, Williams JP.
    Br J Urol; 1973 Jun 22; 45(3):289-98. PubMed ID: 4736519
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical study of terodiline hydrochloride for the treatment of urinary frequency and urinary incontinence, and its cardiovascular adverse effects].
    Yoshihara H, Yasumoto R, Kishimoto T, Maekawa M, Horii A, Nishijima T, Sugimoto T, Kashiwara N, Tsujita M, Senjyu M.
    Hinyokika Kiyo; 1992 Aug 22; 38(8):967-72. PubMed ID: 1414748
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ambulant monitoring to assess the efficacy of oxybutynin chloride in patients with mixed incontinence.
    van Waalwijk van Doorn ES, Zwiers W.
    Eur Urol; 1990 Aug 22; 18(1):49-51. PubMed ID: 2401307
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.